Trulieve Announces Applications Filed for DEA Registration of State Licensed Medical Marijuana Businesses

(High)

(Neutral)

Rhea-AI Summary

Trulieve (OTCQX: TCNNF) filed applications with the U.S. Drug Enforcement Administration to register certain state‑licensed medical marijuana operations under the expedited pathway opened by rescheduling medical marijuana to Schedule III.

For applications submitted within 60 days, licensure to manufacture, distribute, and dispense Schedule III medical marijuana is deemed approved unless the DEA notifies otherwise. Trulieve says it operates over 200 dispensaries serving only medical patients.

Positive

Filed DEA applications for state‑licensed medical marijuana operations
Potential licensure to manufacture, distribute, and dispense Schedule III products
Operates over 200 dispensaries serving medical patients

Negative

Deemed approvals are conditional — valid only "unless otherwise notified" by DEA
Registration applies to state‑licensed medical businesses only, not recreational operations

News Market Reaction – TCNNF

-4.17%

-4.17% Session close to close

In the Apr 29 session, TCNNF declined 4.17%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

04/29/2026 - 03:43 PM

TALLAHASSEE, Fla., April 29, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced that it has filed applications with the U.S. Drug Enforcement Administration (DEA) to register certain state‑licensed medical marijuana operations pursuant to the expedited registration pathway established by the recent rescheduling of medical marijuana to Schedule III under the Controlled Substances Act.

"DEA registration for our medical business marks a historic step forward for Trulieve and the patients we serve," said Trulieve Chief Executive Officer Kim Rivers. "With over 200 dispensaries serving only medical patients, Trulieve is uniquely positioned to set the bar as a responsible operator in U.S. cannabis."

Following the reclassification of medical marijuana to Schedule III, the DEA established an expedited registration process for eligible state‑licensed medical marijuana operators. For operators that apply within 60 days, licensure to manufacture, distribute, and dispense Schedule III medical marijuana products is deemed approved unless otherwise notified.

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with established hubs in the Northeast, Southeast, and Southwest, anchored by cornerstone markets in Arizona, Florida, Ohio, and Pennsylvania. Driven by a core mission to expand access to cannabis, Trulieve serves customers with innovative, high-quality branded products and exceptional experiences. With scaled operations in attractive markets and targeted expansion through its hub strategy, Trulieve is poised for accelerated growth. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve
Instagram: @Trulieve
X: @Trulieve

Investor and Media Contact
Christine Hersey, Chief Corporate Affairs and Strategy Officer
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/trulieve-announces-applications-filed-for-dea-registration-of-state-licensed-medical-marijuana-businesses-302757853.html

SOURCE Trulieve Cannabis Corp.

FAQ

What did Trulieve (TCNNF) file with the DEA on April 29, 2026?

Trulieve filed applications to register certain state‑licensed medical marijuana operations with the DEA. According to Trulieve, the filings seek expedited Schedule III registration after medical marijuana was rescheduled.

Does Trulieve's DEA filing mean immediate federal approval for TCNNF medical operations?

Not immediately — approvals are deemed effective only if the DEA does not notify otherwise. According to Trulieve, applications filed within 60 days are deemed approved unless the DEA issues a different notice.

What activities would DEA registration allow Trulieve (TCNNF) to perform?

DEA registration would allow Trulieve to manufacture, distribute, and dispense Schedule III medical marijuana products. According to Trulieve, the expedited pathway covers those licensure categories for eligible state‑licensed operators.

How many dispensaries does Trulieve say could be affected by the DEA registration?

Trulieve states it operates over 200 dispensaries serving only medical patients. According to Trulieve, that footprint positions the company to pursue registration under the expedited Schedule III process.

Is the DEA expedited registration pathway time‑limited for companies like Trulieve (TCNNF)?

Yes — the expedited process references a 60‑day application window for deemed approvals. According to Trulieve, operators applying within 60 days are deemed approved unless otherwise notified by the DEA.

Will DEA registration for Trulieve (TCNNF) cover recreational cannabis operations?

No — the filings relate to state‑licensed medical marijuana operations only. According to Trulieve, the expedited Schedule III registration pathway applies specifically to medical operators.